WO1998034590A1 - Composition active contre les effets du froid et produit cosmetique comportant une telle composition - Google Patents
Composition active contre les effets du froid et produit cosmetique comportant une telle composition Download PDFInfo
- Publication number
- WO1998034590A1 WO1998034590A1 PCT/FR1998/000180 FR9800180W WO9834590A1 WO 1998034590 A1 WO1998034590 A1 WO 1998034590A1 FR 9800180 W FR9800180 W FR 9800180W WO 9834590 A1 WO9834590 A1 WO 9834590A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- weight
- active composition
- composition according
- composition
- cold
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 46
- 230000000694 effects Effects 0.000 title claims abstract description 14
- 239000002537 cosmetic Substances 0.000 title claims abstract description 13
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 14
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 14
- 150000004676 glycans Chemical class 0.000 claims abstract description 9
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 9
- 239000005017 polysaccharide Substances 0.000 claims abstract description 9
- 150000001413 amino acids Chemical class 0.000 claims abstract description 7
- 235000018102 proteins Nutrition 0.000 claims description 13
- 229920000715 Mucilage Polymers 0.000 claims description 8
- 239000000853 adhesive Substances 0.000 claims description 8
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 7
- 229920002527 Glycogen Polymers 0.000 claims description 6
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 6
- 235000001014 amino acid Nutrition 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 6
- 229940096919 glycogen Drugs 0.000 claims description 6
- 241000218652 Larix Species 0.000 claims description 5
- 235000005590 Larix decidua Nutrition 0.000 claims description 5
- 230000001681 protective effect Effects 0.000 claims description 5
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 4
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 4
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 4
- 235000004279 alanine Nutrition 0.000 claims description 4
- 241000218631 Coniferophyta Species 0.000 claims description 3
- 241000219745 Lupinus Species 0.000 claims description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 2
- 235000010523 Cicer arietinum Nutrition 0.000 claims description 2
- 244000045195 Cicer arietinum Species 0.000 claims description 2
- 108010082495 Dietary Plant Proteins Proteins 0.000 claims description 2
- 235000010469 Glycine max Nutrition 0.000 claims description 2
- 244000068988 Glycine max Species 0.000 claims description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 2
- 240000004713 Pisum sativum Species 0.000 claims description 2
- 235000010582 Pisum sativum Nutrition 0.000 claims description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 2
- 239000004473 Threonine Substances 0.000 claims description 2
- 235000021374 legumes Nutrition 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 description 8
- 210000003491 skin Anatomy 0.000 description 7
- 230000009471 action Effects 0.000 description 6
- 229960003767 alanine Drugs 0.000 description 5
- 210000002196 fr. b Anatomy 0.000 description 5
- 210000003918 fraction a Anatomy 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 229960002429 proline Drugs 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 210000000540 fraction c Anatomy 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 3
- 229930182821 L-proline Natural products 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 239000005662 Paraffin oil Substances 0.000 description 2
- 230000004308 accommodation Effects 0.000 description 2
- 230000002528 anti-freeze Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000008269 hand cream Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N n-hexadecyl alcohol Natural products CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 230000006911 nucleation Effects 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000001012 protector Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000004781 supercooling Methods 0.000 description 2
- 229920000189 Arabinogalactan Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 108010084695 Pea Proteins Proteins 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000019312 arabinogalactan Nutrition 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N beta-monoglyceryl stearate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000002032 cellular defenses Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229940080284 cetyl sulfate Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000000959 cryoprotective effect Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- HJQLXIPVQPEJRY-UHFFFAOYSA-N hexadecyl 3,5,5-trimethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CC(C)CC(C)(C)C HJQLXIPVQPEJRY-UHFFFAOYSA-N 0.000 description 1
- LPTIRUACFKQDHZ-UHFFFAOYSA-N hexadecyl sulfate;hydron Chemical compound CCCCCCCCCCCCCCCCOS(O)(=O)=O LPTIRUACFKQDHZ-UHFFFAOYSA-N 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000019702 pea protein Nutrition 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- NWZBFJYXRGSRGD-UHFFFAOYSA-M sodium;octadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCCCOS([O-])(=O)=O NWZBFJYXRGSRGD-UHFFFAOYSA-M 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 229950003429 sorbitan palmitate Drugs 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/24—Thermal properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Definitions
- the present invention relates to the field of protection against cold and the prevention of risks and the repair of damage linked to the action of cold, in particular on the skin, and relates to an active composition against the effects of cold, as well as a cosmetic product comprising such a composition.
- the gel kills most living cells and the ice crystals that form inside and outside the cells by freezing the intra- and extracellular medium, tear the cell membranes, and damage the subcellular organelles. The cells then empty themselves of their contents, and the cellular metabolisms are deteriorated.
- frost resistance consists in fact of a phenomenon of accommodation and results from the accumulation in the aerial parts of protective substances such as sugars, antioxidants and specific proteins, inhibiting nucleation or allowing inhibition controlled nucleation of ice crystals.
- the problem posed by the present invention consists, on the basis of the aforementioned observations, of designing and obtaining an active composition the implementation or application of which induces an action of the supercooling type and an action of the gel accommodation type, by providing target cells (especially skin cells) with the elements necessary to combat the effects of the cold.
- the subject of the present invention is a composition active against the effects of the cold, characterized in that it is composed by a mixture of at least one polysaccharide, amino acids and proteins or proteins.
- This active composition can preferably be constituted, essentially, by 0.1% to 30% by weight of at least one polysaccharide, by 45% to 95% by weight of proteins or proteins and by 0.1% to 25% by weight of amino acids.
- the at least one polysaccharide comprises at least one mucilage extracted from plants and preferably belonging to the family of arabinogalactans, in particular extracted from conifers or plants such as corn.
- This type of substance has anti-dehydrating, cryoprotective and inhibitory properties for the growth of ice crystals.
- the active composition can comprise, as polysaccharides, between 0.1% and 10% by weight of glycogen and between 0.1% and 20% by weight of mucilages, in particular extracts of conifers, especially larch.
- Glycogen preserves the viability and vitality of cells, even frozen, and is a source of energy because of its possible conversion to glucose, even at low temperatures.
- the active composition advantageously comprises between 45% and 95% by weight of vegetable proteins extracted from legumes, in particular from soybeans, peas, beans, lupine, beans, chickpeas or the like. .
- These thermostable polypeptide fractions have properties of inhibiting the crystallization of water ("antifreeze” activity), as well as anti-free radical and antioxidant actions.
- the specific amino acids integrated into the active composition in accordance with the invention must advantageously indicate an osmotic action can be chosen, for example, from the group formed by threonine, serine, proline and alanine.
- the active composition comprises, on the one hand, between 0.1% and 20% by weight of proline and, on the other hand, between 0.1% and 5% by weight. alanine weight.
- said active composition acts in a triple fashion, namely, on the one hand, as a cellular protector, by inhibiting the damage caused by the cold on cells, their membranes, their organelles and their functions, on the other hand, as a skin protector and repairer against cold-related damage (action against skin dryness, lack or loss of flexibility or elasticity, discomfort, tightness or the like) and, finally, as an inducer of a potentiation of cellular defenses against the effects of cold and frost.
- various examples of composition are given below, mentioned for purely illustrative and nonlimiting purposes.
- the present invention also relates to a protective and repairing cosmetic product, intended to be applied to the skin, characterized in that it comprises an active composition as described above, in particular with a constituent fraction of between 1% and 50 % in weight.
- this cosmetic product will comprise between 5% and 10% by weight of active composition according to the invention.
- various cosmetic products or preparations for topical use for the skin will be described below, comprising a determined amount of the active composition described above and compatible with such an application.
- Example 1 A cosmetic product in the form of sunscreen intended for use during winter sports and in accordance with the invention could, for example, have a weight composition, constituted from the following fractions A, B and C, such as indicated below. Fraction A - Cetyl alcohol 2,000
- a cosmetic product in the form of an emulsion for the face and of protective day care may, for example, have a weight composition, constituted from the following fractions A, B and C, as indicated below.
- Example 3 The process for preparing and manufacturing the emulsion for the face described above is substantially identical to the process described with reference to Example 1.
- Example 3 The process for preparing and manufacturing the emulsion for the face described above is substantially identical to the process described with reference to Example 1.
- a cosmetic product in the form of a hand cream may, for example, have a weight composition, constituted from the following fractions A, B and C, as indicated below.
- Fraction A Cetostearyl alcohol and cetyl / sodium stearyl sulfate 7,000
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU61044/98A AU6104498A (en) | 1997-02-11 | 1998-01-30 | Active composition for combating the effects of the cold and cosmetic product containing this composition |
EP98905471A EP0983045A1 (fr) | 1997-02-11 | 1998-01-30 | Composition active contre les effets du froid et produit cosmetique comportant une telle composition |
US09/367,224 US6224889B1 (en) | 1997-02-11 | 1998-01-30 | Active composition for combating the effects of the cold and cosmetic product containing this composition |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR97/01711 | 1997-02-11 | ||
FR9701711A FR2759295B1 (fr) | 1997-02-11 | 1997-02-11 | Composition active contre les effets du froid et produit cosmetique comportant une telle composition |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998034590A1 true WO1998034590A1 (fr) | 1998-08-13 |
Family
ID=9503696
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR1998/000180 WO1998034590A1 (fr) | 1997-02-11 | 1998-01-30 | Composition active contre les effets du froid et produit cosmetique comportant une telle composition |
Country Status (5)
Country | Link |
---|---|
US (1) | US6224889B1 (fr) |
EP (1) | EP0983045A1 (fr) |
AU (1) | AU6104498A (fr) |
FR (1) | FR2759295B1 (fr) |
WO (1) | WO1998034590A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6030620A (en) * | 1997-07-25 | 2000-02-29 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Skin care compositions containing an organic extract of chick pea |
KR100574848B1 (ko) * | 1999-10-21 | 2006-04-27 | 주식회사 코리아나화장품 | 강낭콩 추출물을 함유하는 화장료 조성물 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1057277A (en) * | 1963-03-01 | 1967-02-01 | Union Carbide Corp | Improvements in and relating to preservation of cells |
US4711780A (en) * | 1984-06-11 | 1987-12-08 | Fahim Mostafa S | Composition and process for promoting epithelial regeneration |
US5391373A (en) * | 1992-07-01 | 1995-02-21 | Chanel, Inc. | Skin cream composition |
US5420106A (en) * | 1994-03-22 | 1995-05-30 | Bristol-Myers Squibb Company | Method and composition having enhanced alpha-hydroxy acid skin permeation and retention |
WO1996028008A2 (fr) * | 1996-03-19 | 1996-09-19 | Guerlain S.A. | Compositions cosmetiques et dermatologiques pour lutter contre le vieillissement de la peau |
US5571503A (en) * | 1995-08-01 | 1996-11-05 | Mausner; Jack | Anti-pollution cosmetic composition |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60226588A (ja) * | 1984-04-24 | 1985-11-11 | Kanegafuchi Chem Ind Co Ltd | 酵素修飾蛋白質系不凍剤 |
JP2965322B2 (ja) * | 1990-05-31 | 1999-10-18 | サントリー株式会社 | 皮膚外用剤 |
-
1997
- 1997-02-11 FR FR9701711A patent/FR2759295B1/fr not_active Expired - Fee Related
-
1998
- 1998-01-30 EP EP98905471A patent/EP0983045A1/fr not_active Withdrawn
- 1998-01-30 AU AU61044/98A patent/AU6104498A/en not_active Abandoned
- 1998-01-30 US US09/367,224 patent/US6224889B1/en not_active Expired - Fee Related
- 1998-01-30 WO PCT/FR1998/000180 patent/WO1998034590A1/fr not_active Application Discontinuation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1057277A (en) * | 1963-03-01 | 1967-02-01 | Union Carbide Corp | Improvements in and relating to preservation of cells |
US4711780A (en) * | 1984-06-11 | 1987-12-08 | Fahim Mostafa S | Composition and process for promoting epithelial regeneration |
US5391373A (en) * | 1992-07-01 | 1995-02-21 | Chanel, Inc. | Skin cream composition |
US5420106A (en) * | 1994-03-22 | 1995-05-30 | Bristol-Myers Squibb Company | Method and composition having enhanced alpha-hydroxy acid skin permeation and retention |
US5571503A (en) * | 1995-08-01 | 1996-11-05 | Mausner; Jack | Anti-pollution cosmetic composition |
WO1996028008A2 (fr) * | 1996-03-19 | 1996-09-19 | Guerlain S.A. | Compositions cosmetiques et dermatologiques pour lutter contre le vieillissement de la peau |
Also Published As
Publication number | Publication date |
---|---|
FR2759295B1 (fr) | 1999-04-16 |
EP0983045A1 (fr) | 2000-03-08 |
US6224889B1 (en) | 2001-05-01 |
FR2759295A1 (fr) | 1998-08-14 |
AU6104498A (en) | 1998-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0558509B1 (fr) | Utilisation de saponines de medicago pour la preparation de compositions cosmetiques ou pharmaceutiques, notamment dermatologiques favorisant le renouvellement de l'epiderme, stimulant la repousse des cheveux, ou retardant leur chute | |
CN105662923A (zh) | 一种含有牡丹籽油的纯天然多效修复变色润唇膏及其制备方法 | |
EP3092041B1 (fr) | Utilisation cosmetique d'un extrait d'artemia salina pour proteger la peau des stress thermiques froids | |
JP5009594B2 (ja) | 抗菌性のある不凍タンパク質含有植物抽出物 | |
FR2779645A1 (fr) | Compositions a usage cosmetique ou dermopharmaceutique contenant un melange d'extrait de cafe vert et de beurre de karite | |
CN110478288A (zh) | 一种皮肤抗衰老组合成分 | |
WO1998034590A1 (fr) | Composition active contre les effets du froid et produit cosmetique comportant une telle composition | |
EP1176946B1 (fr) | Composition cosmetique contenant des huiles de cynara cardunculus ou de silybum marianum | |
FR2912311A1 (fr) | Composition comprenant de l'huile d'argan et un produit a base de plante du genre aloe, et son utilisation cosmetique | |
EP0279136A2 (fr) | Cosmétique pour retarder le vieillissement de la peau et procédé d'application | |
JP2006117592A (ja) | マトリックスメタロプロテアーゼ−2阻害剤 | |
CN108969464B (zh) | 防冻伤组合物及其制备方法和应用 | |
WO2004052323A1 (fr) | Extrait de sesame radiculaire et produit cosmetique pour les cheveux | |
WO2008145855A1 (fr) | Composition pharmaceutique et/ou cosmetique contenant un principe actif activateur du cytochrome c | |
EP1778162B1 (fr) | Utilisation d'un extrait de triticum monococcum comme principe actif dans une composition cosmetique et/ou pharmaceutique | |
JP3900977B2 (ja) | 皮膚化粧料及び美容用飲食品 | |
FR2957258A1 (fr) | Composition cosmetique. | |
CH686999A5 (fr) | Composition cosmétique à effet rééquilibrant anti-stress. | |
Yunus | Antioxidant Properties of Honey: Mechanisms and Clinical Applications | |
EP4230187A1 (fr) | Produit cosmétique à dose unique et son procédé de fabrication | |
WO2008145854A1 (fr) | Composition pharmaceutique et/ou cosmetique contenant des peptides | |
FR3015278A1 (fr) | Macerat huileux de patiron ( cucurbita maxima ) pour un usage cosmetique | |
CH686997A5 (fr) | Composition cosmétique à effet raffermissant. | |
KR102117661B1 (ko) | 울릉국화, 미역취 및 전호 혼합추출물을 유효성분으로 함유하는 피부 주름개선 및 항노화용 화장료 조성물 | |
FR2824476A1 (fr) | Composition cosmetique permettant a la peau de s'adapter aux conditions de stress thermique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA JP KR US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1998905471 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09367224 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 1998533865 Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: 1998905471 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1998905471 Country of ref document: EP |